THBD and acute promyelocytic leukemia: Thrombomodulin, an anticoagulant normally expressed by endothelial cells that binds thrombin—leading to protein C activation and cleavage of factors V and VIII—has shown promise in stabilizing the coagulopathy of APL in limited retrospective studies [131].